Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWQNP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,547
Award facts
- Contract value 100% obligated
- $1,547.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Xolair 150 mg/ml syringes. The contract, valued at $1,547.40, operates under a firm fixed-price structure with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. The place of performance is located in Park Ridge, Illinois, where the company maintains its operations as a primary pharmaceutical distributor to federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC establishes DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive pharmaceutical products including prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. The award of this Xolair delivery order reflects the company's established role in supporting military medical supply requirements through the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FWQNP?
SPE2DB25FWQNP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FWQNP worth?
The government has obligated $1,547 on SPE2DB25FWQNP.
Is contract SPE2DB25FWQNP an order under another contract?
Yes. SPE2DB25FWQNP is a delivery order under SPE2DB25D9307, an indefinite delivery contract.
Was contract SPE2DB25FWQNP competed?
The extent of competition for SPE2DB25FWQNP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award